Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Latest News about SNY

Recent news which mentions SNY

< Previous 1 2
...
10 11 12 13 14 15 16 17 18
...
29 30 Next >
Sanofi-Regeneron Highlight Dupixent Data, Say Drug Benefit Was Swift, Sustained
Tickers REGN SNY
Tags General Large Cap REGN
From Benzinga
2 Bear Market Defying Stocks to Buy in May
Tickers AXSM SNY
Tags Market News Recent Press Releases SNY
From Motley Fool
FDA advisers vote in favor of Pfizer’s maternal RSV vaccine
Tickers AZN GSK PFE SNY
Tags GSK SNY SPX
From MarketWatch
Roche's Investigational Drug For Relapsing Multiple Sclerosis Reduces Brain Lesions, Data Shows
Tickers MKGAF RHHBF RHHBY RHHVF
Tags Market News SNY Biotech
From Benzinga
AI Meets Biotech: Transforming the Drug Development Process
Tickers AZN BAYRY RHHBY SNY
Tags OTCMKTS:BAYRY,OTCMKTS:RHHBY,Nasdaq:SNY,Nasdaq:AZN BAYRY RHHBY
From InvestorPlace
Peering Into Sanofi's Recent Short Interest
Tickers SNY
Tags SNY BZI/SHORTHIST Market News
From Benzinga
Rebates or Patent Abuse? Eli Lilly, Novo Nordisk, and Sanofi CEOs Cross Swords with PBMs in Senate Hearing
Tickers CI LLY NVO SNY
Tags LLY UNH Health Care
From Benzinga
Sanofi, AstraZeneca Release Real-World Data For Respiratory Syncytial Virus Antibody
Tickers AZN AZNCF GSK SNY
Tags GSK SNY AZNCF
From Benzinga
Prescription-drug costs in spotlight as pharmacy benefit reform advances in Senate
Tickers CI CVS LLY NVO
Tags LLY CI CVS
From MarketWatch
Fabry Disease Treatment Showdown: Protalix Bio's Elfabrio Joins the Ranks of Sanofi and Amicus Therapeutics
Tickers FOLD PLX SNY
Tags Health Care Benzinga Biotech
From Benzinga
7 Blue-Chip Stocks to Buy in May 2023
Tickers AMGN FRC JPM LMT
Tags JPM TSM SNY
From InvestorPlace
Why Regeneron Pharmaceuticals Shares Are Trading Lower Today
Tickers REGN SNY
Tags Large Cap REGN Movers
From Benzinga
7 Stock Upgrades and Downgrades Alerts You Cannot Ignore
Tickers ABBV INTC MSFT MXL
Tags ABBV MSFT NYSE:ABBV,NASDAQ:INTC,NASDAQ:MSFT,NASDAQ:MXL,NYSE:NET,NASDAQ:SNY,NASDAQ:TSCO
From InvestorPlace
First Republic Folds Amid Banking Crisis, Elon Musk Expects Starship To Make Orbit On Next Launch, DOJ Probes Mastercard Over Anti-Competitive Debit-Card Practices: Today's Top Stories
Tickers ADDYY ALPMY BLMN BNTX
Tags CS BLMN DB
From Benzinga
European Union's Amended COVID-19 Vaccine Deal with Pfizer-BioNTech: Near-Monopoly Status Potential Threat to Rivals
Tickers BNTX MRNA NVAX PFE
Tags Biotech Benzinga Health Care
From Benzinga
Sanofi In-Licenses Pompe Disease Therapy From Privately-Held Maze Therapeutics For $150M Upfront
Tickers SNY
Tags SNY Market News News
From Benzinga
Sanofi (SNY) Q1 2023 Earnings Call Transcript
Tickers SNY
Tags Market News Recent Press Releases SNY
From Motley Fool
Sanofi Posts Upbeat Q1 Earnings, Sales Buoyed By Blockbuster Dupixent Sales
Tickers REGN SNY
Tags News Earnings Health Care
From Benzinga
Earnings Scheduled For April 27, 2023
Tickers OPRA ORC ORI OSK
Tags SGEN STRA SNCY
From Benzinga
US Stocks Eye Higher Open As Meta Q1 Uplifts Tech Sector: Analyst Says 'No Earnings Recession In Cards Yet'
Tickers AAL ABBV AMGN AMZN
Tags EBAY HAS AMZN
From Benzinga
Earnings Outlook For Sanofi
Tickers SNY
Tags SNY Market News Earnings
From Benzinga
Johnson & Johnson Unleashes Kenvue: Tylenol to Neutrogena, $40B Revenue Unit Spinoff Preps for IPO Blitz
Tickers BAYRY GSK HLN INTC
Tags Briefs INTC News
From Benzinga
United Nations' Specialized Agency In Preliminary Talks With Takeda For Dengue Vaccine, Currently Under FDA Review
Tickers GSK MRK SNY TAK
Tags Government GSK SNY
From Benzinga
Tiziana Life Sciences Has Only Fully Human Anti-CD3 mAB In Clinical Studies, Could Be Poised To Improve Care For Patients With Severe Multiple Sclerosis
Tickers EWTX IPHA PRVB SGEN
Tags IPHA Partner Content PRVB
From Benzinga
Cancer And Diabetes Remain Among The Deadliest And Most Debilitating Diseases — Is Gene Therapy The Solution? One Company, Genprex, Inc. (NASDAQ: GNPX), Thinks So
Tickers AMGN AZN BIIB BLUE
Tags BLUE General NVO
From Benzinga
Treatments For Non-Active Secondary Progressive Multiple Sclerosis Remain Scarce – Tiziana Life Sciences' (NASDAQ: TLSA) First-In-Class Foralumab Is Showing Promise
Tickers PRVB SNY TLSA
Tags Tiziana Life Sciences Benzinga Biotech
From Benzinga
Sanofi's $3B Acquisition Of Provention Bio Hits Regulatory Roadblock: FTC Requests More Information
Tickers PRVB SNY
Tags SNY Market News News
From Benzinga
Hillstream BioPharma's Drug Candidate HSB-1216 Could Be One To Watch As Global Oncology Market Continues To Grow
Tickers BGNE BMY CRMD DD
Tags CRMD DD HILS
From Benzinga
Hillstream BioPharma's Drug Candidate HSB-1216 Could Be One To Watch As Global Oncology Market Continues To Grow
Tickers BGNE BMY CRMD DD
Tags ILMN BGNE BMY
From Benzinga
2 Top Healthcare Stocks Defying the Bear Market
Tickers MCK SNY
Tags SNY Market News Recent Press Releases
From Motley Fool
< Previous 1 2
...
10 11 12 13 14 15 16 17 18
...
29 30 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.